Replies to post #106424 on Biotech Values

[DewDiligence]

Bloomberg article on Botox for migraine has a serious factual error:

http://www.bloomberg.com/news/2010-10-15/allergan-says-u-s-fda-approved-botox-as-treatment-for-chronic-migraines.html

What is the error?

[DewDiligence]

Mostly-fluff piece from Fortune on AGN’s winning ways:

http://money.cnn.com/2011/06/09/magazines/fortune/botox_allergan_patent_cliff_big_pharma.fortune/index.htm

The one notable point in the article is that investors and analysts may be underestimating the sales potential of Botox for migraine, an indication approved by the FDA in Oct 2010 (#msg-55606649).